First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry
2019 ◽
Vol 70
(1)
◽
pp. e113-e114
◽
2019 ◽
Vol 114
(1)
◽
pp. S599-S600
2008 ◽
Vol 27
(9)
◽
pp. 790-797
◽
2016 ◽
Vol 64
(2)
◽
pp. S218-S219
◽
Keyword(s):